Cutting edge:: Monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses

被引:43
|
作者
Dennehy, Kevin M.
Elias, Fernando
Zeder-Lutz, Gabrielle
Ding, Xin
Altschuh, Daniele
Luehder, Fred
Huenig, Thomas
机构
[1] Univ Wurzburg, Inst Virol & Immunbiol, D-97078 Wurzburg, Germany
[2] Univ Cape Town, Observ, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa
[3] Ecole Super Biotechnol Strasbourg, CNRS, UMR 7175, Illkirch Graffenstaden, France
[4] TeGenero Immunotherapeut, Wurzburg, Germany
[5] Inst Multiple Sklerose Forsch, Gottingen, Germany
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 10期
关键词
D O I
10.4049/jimmunol.176.10.5725
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 and CTLA-4 are the major costimulatory receptors on naive T cells. But it is not clear why CD28 is monovalent whereas CTLA-4 is bivalent for their shared ligands CD80186. We generated bivalent CD28 constructs by fusing the extracellular domains of CTLA-4 or CD80 with the intracellular domains of CD28. Bivalent or monovalent CD28 constructs were ligated with recombinant ligands with or without TCR coligation. Monovalent CD28 ligation did not induce responses unless the TCR was coligated. By contrast, bivalent CD28 ligation induced responses in the absence of TCR engagement. To extend these findings to primary cells, we used novel superagonistic and conventional CD28Abs. Superagonistic Ab D665, but not conventional Ab E18, predominantly ligates CD28 bivalently at low CD28/Ab ratios and induces A&independent - T cell proliferation. Monovalency of CD28 for its natural ligands is thus essential toprovide costimulation without inducing responses in the absence of TCR engagement.
引用
收藏
页码:5725 / 5729
页数:5
相关论文
共 50 条
  • [31] Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor
    Tian, Ruijun
    Wang, Haopeng
    Gish, Gerald D.
    Petsalaki, Evangelia
    Pasculescu, Adrian
    Shi, Yu
    Mollenauer, Marianne
    Bagshaw, Richard D.
    Yosef, Nir
    Hunter, Tony
    Gingras, Anne-Claude
    Weiss, Arthur
    Pawson, Tony
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (13) : E1594 - E1603
  • [32] Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway
    Ndejembi, Modesta P.
    Teijaro, John R.
    Patke, Deepa S.
    Bingaman, Adam W.
    Chandok, Meena R.
    Azimzadeh, Agnes
    Nadler, Steven G.
    Farber, Donna L.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (11): : 7698 - 7706
  • [33] Cutting edge:: CD28 controls peripheral homeostasis of CD4+CD25+
    Tang, QZ
    Henriksen, KJ
    Boden, EK
    Tooley, AJ
    Ye, JQ
    Subudhi, SK
    Zheng, XX
    Strom, TB
    Bluestone, JA
    JOURNAL OF IMMUNOLOGY, 2003, 171 (07): : 3348 - 3352
  • [34] The T cell surface protein, CD28
    Edmead, CE
    Lamb, JR
    Hoyne, GF
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (8-9): : 1053 - 1057
  • [35] CD28 AND T-CELL ACTIVATION
    OLIVE, D
    VANLIER, R
    RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 127 - 129
  • [36] Differentiation and Activation of γδ T Lymphocytes: Focus on CD27 and CD28 Costimulatory Receptors
    Ribot, Julie C.
    Silva-Santos, Bruno
    CROSSROADS BETWEEN INNATE AND ADAPTIVE IMMUNITY IV, 2013, 785 : 95 - 105
  • [37] Cutting edge:: Regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination
    Zhang, J
    Bárdos, T
    Li, DD
    Gál, I
    Vermes, C
    Xu, JY
    Mikecz, K
    Finnegan, A
    Lipkowitz, S
    Glant, TT
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2236 - 2240
  • [38] Regulation of CD4+T cell responses: The impact of limiting CD28 costimulation
    Briggs, Zoe
    Sansom, David
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [39] The roles of CD28 and cytotoxic T-lymphocyte antigen-4 in immune responses
    Alegre, ML
    Noel, PJ
    Chuang, E
    Thompson, CB
    IMMUNE TOLERANCE: INTERNATIONAL SYMPOSIUM ON IMMUNE TOLERANCE, 1996, : 187 - 196
  • [40] POTENT T CELL COSTIMULATION MEDIATED BY A NOVEL COSTIMULATORY ANTIGEN RECEPTOR (COSTAR) WITH DUAL CD28/CD40 SIGNALING DOMAINS TO IMPROVE ADOPTIVE CELL THERAPIES
    Sykorova, Martina
    Bao, Leyuan
    Chauvin-Fleurence, Cynthia
    Kalaitsidou, Milena
    Le Brocq, Michelle
    Hawkins, Robert
    Kueberuwa, Gray
    Bridgeman, John
    Alvarez-Rodriguez, Ruben
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A210 - A210